GlassScriptPhysician profile
Lauren B Davidson
NPI 1255975892
$3,347.45
in general payments reported to CMS, 2019-2025
19 companies · $609 in 2025
The $609 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $394 · 2023: $995 · 2024: $893 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,496.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $826.10 | 2021-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $656.53 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $650.39 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $209.68 | 2023-2025 | Jelmyto |
| Janssen Biotech, INC. | $177.75 | 2021-2025 | Erleada, Akeega, Balversa |
| Astrazeneca Pharmaceuticals LP | $175.47 | 2021-2024 | Lynparza |
| Endo USA, INC. | $96.68 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $90.63 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Endo Pharmaceuticals INC. | $83.28 | 2022-2024 | Xiaflex, Aveed |
| Coloplast Corp | $75.34 | 2022 | |
| Ferring Pharmaceuticals INC. | $72.22 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $51.52 | 2023-2024 | Axonics, Bulkamid |
| Convatec INC. | $47.97 | 2023 | |
| Urovant Sciences INC | $28.19 | 2021-2022 | |
| Tolmar, INC. | $24.72 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $24.52 | 2023 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $23.24 | 2024 | |
| Procept Biorobotics Corporation | $19.58 | 2022 | |
| Pfizer INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.